Davis-based company raises funds to research alternatives to opioids

Davis-based Expanesthetics Inc. has picked up another $1.83 million in venture capital to bolster its research of new “inhaled” anesthetic products and alternatives to opioids.  The company raised $1.39 million in equity during a recent general solicitation, and raised $445,000 through a securities offering to existing shareholders, according to Securities and Exchange Commission documents filed on March 4.  Expanesthetics has been gradually accruing funds since February 2017, when it raised…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news